CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 13, 2006--ARIAD Pharmaceuticals, Inc. (Nasdaq: ARIA) today announced that Harvey J. Berger, M.D., chairman and chief executive officer of ARIAD, will be participating in a Focus Session on "Cancer: New Mechanisms of Action for Cancer Treatment" at the 8th Annual BIO CEO & Investor Conference 2006 at the Waldorf-Astoria in New York, New York, on Tuesday, February 14, 2006 at 4:00 p.m. (EST). The session will be webcast beginning approximately twelve hours after the presentation and can be accessed by visiting the investor relations section of the Company's website at http://www.ariad.com/investor.
